Skip to content

Multimodal prediction of MCI-to-dementia conversion over a two-year window.

Sep 2026 · GeroScience · 1 citation · ⚡ 1 influential · 37 references
Medicine

TL;DR

An explainable multimodal machine-learning framework to predict progression from MCI to dementia within a clinically meaningful two-year period is developed and the convergence of cognitive impairment and region-specific neurodegeneration emerged as the strongest indicator of conversion risk.

View source

Similar papers

Open access Sep 2026

Modelling the risk of conversion from mild cognitive impairment to Alzheimer’s disease using machine learning

Mild cognitive impairment (MCI) is a transitional state between normal aging and dementia, characterized by subtle cognitive decline. While not all individuals with MCI will progress to Alzheimer’s disease (AD), early identification of those at high risk is crucial for timely interventions. Machine learning algorit...

A. Mouiha, Mohamed Taiebine, Jaouad El-Hilaly · 0 citations
Open access Sep 2026

Predicting Conversion from SCD to MCI: A Machine Learning Study

BACKGROUND: Subjective cognitive decline (SCD) may precede mild cognitive impairment (MCI), but not all individuals with SCD progress to MCI. Identifying which individuals are most likely to convert and over what time frame remains an important goal in Alzheimer's disease research. MRI measures of white matter hyperint...

F. Kamal, A. Metz, K. Chadwick et al. · 0 citations
Open access Sep 2026

Comparative Value of Cognitive and Functional Assessments for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease: An ADNI Cohort Study

Episodic memory demonstrated the strongest predictive performance among the individual assessment domains evaluated of 24-month progression from MCI to AD, with functional assessment providing substantial complementary value.

S. Choe · 0 citations
Sep 2026

Utility of biomarkers in prediction of future cognition in Alzheimer's disease continuum changes over time.

BackgroundWhile multiple biomarkers of Alzheimer's disease (AD) and mild cognitive impairment (MCI) predict cognitive decline over time, their predictive value at each of the disease stages remains unclear.ObjectiveTo examine how the predictive power of biomarkers changes over time.MethodsWe dynamically ranked a compre...

E. Ramezannezhad, Mohammad Dehghani · 0 citations
Open access Sep 2026

A Machine Learning Framework for Binary and Multiclass Classification of Cognitive Impairment Using Structural MRI Biomarkers

The findings support the potential role of structural MRI biomarkers combined with interpretable ML approaches for the classification of cognitive impairment and the integration of demographic variables improved model performance, particularly in binary discrimination tasks, whereas multiclass classification remained m...

Alessia Venuto, Ambra Faraci, Alessandro Grimaldi et al. · 0 citations
Conference

Predicting Cognitive Decline in Healthy Adults using Structural MRI

Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, affecting millions globally. As populations continue to age, AD prevalence is expected to rise significantly, placing substantial burdens on healthcare systems. Early detection of cognitive decline is essential, as interv...

Samaneh Rezaeimanesh, Mohammad Fili, Gui-Ping Hu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.